Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nosotti M et al. - Immunocytochemical analysis detects occult tumor cells in the bone marrow of at least 25% of pt surgically treated for stage I and II non-small-cell lung cancer (NSCLC); these occult tumor cells have no impact on the disease-free interval

Methods

Results